Detalhe da pesquisa
1.
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease.
Nat Immunol
; 25(4): 607-621, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589621
2.
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic, Omalizumab, in Severe Asthma in Adults: Results of the SoMOSA Study.
Am J Respir Crit Care Med
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635834
3.
Airway hyperresponsiveness in asthma: The role of the epithelium.
J Allergy Clin Immunol
; 153(5): 1181-1193, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38395082
4.
Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial.
N Engl J Med
; 385(18): 1669-1679, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706172
5.
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.
N Engl J Med
; 384(19): 1800-1809, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33979488
6.
Dexamethasone in Hospitalized Patients with Covid-19.
N Engl J Med
; 384(8): 693-704, 2021 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32678530
7.
Airway remodelling in asthma and the epithelium: on the edge of a new era.
Eur Respir J
; 63(4)2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609094
8.
The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma.
Eur Respir J
; 63(4)2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453256
9.
Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.
Clin Endocrinol (Oxf)
; 100(4): 317-327, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38229583
10.
Biomarkers and clinical outcomes after tezepelumab cessation: extended follow-up from the 2-year DESTINATION study.
Ann Allergy Asthma Immunol
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697286
11.
Accelarated immune ageing is associated with COVID-19 disease severity.
Immun Ageing
; 21(1): 6, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212801
12.
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control.
J Allergy Clin Immunol
; 152(4): 876-886, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315813
13.
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID.
Eur Respir J
; 61(5)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922030
14.
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Am J Respir Crit Care Med
; 205(1): 17-35, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34658302
15.
Feno differentiates epithelial gene expression clusters: Exploratory analysis from the MESOS randomized controlled trial.
J Allergy Clin Immunol
; 150(4): 830-840, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35537502
16.
Benralizumab for the Prevention of COPD Exacerbations.
N Engl J Med
; 381(11): 1023-1034, 2019 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31112385
17.
Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19.
Thorax
; 77(7): 717-720, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354642
18.
Lysyl oxidase like 2 is increased in asthma and contributes to asthmatic airway remodelling.
Eur Respir J
; 60(1)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996828
19.
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
Eur Respir J
; 59(4)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561291
20.
Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.
Allergy
; 77(11): 3362-3376, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778780